OmniGuide(TM) Holdings and UROTECH (Medi-Globe Group Subsidiary) Announce Partnership to Expand Global Urology Patient Therapies

BOSTON / ACCESSWIRE / February 22, 2024 / OmniGuide™ Holdings (OGH) and UROTECH® (part of the Medi-Globe Group, a subsidiary of DCC plc) have announced a new partnership to strengthen UROTECH’s technology portfolio for urologists. As part of the collaboration, the partnership will work with urologists to build a global network for RevoLix™ HTL (Hybrid Thulium Laser Therapy) specifically for kidney stones and benign prostatic hyperplasia (BPH).

UROTECH is one of the leading medical technology manufacturers in the field of minimally invasive urology. The treatment of kidney stones is at the heart of UROTECH’s work, which is committed to the highest quality standards for its products and clinical experience. As a determined and reliable medical partner, UROTECH supports the daily work of urologists.

Surgeons and nurses recognize OmniGuide’s ability to deliver advanced solutions for some of the most important surgical therapies in urology. OmniGuide’s innovative focus on robotics, precision light therapies and biosensing software enables the company to cover a wide range of urological procedures and reduce complications every day.

The aim of the global collaboration is to support future surgical trends by providing access to data and insights for urological decisions. The partnership will accelerate these efforts as two global companies work toward a common goal and bring their surgical expertise.

OmniGuide Urology will support projects with UROTECH including:

  • Scaling global capacity for Kidney Stones and BPH Treatments through the newly launched RevoLix™ HTL Hybrid Thulium Laser.
  • User-centered strategies for existing urologists, delivering solutions to better support a great clinical experience.
  • Increase advocacy through partnering and establishing a forum in urology.
  • Developing a biosensing software platform in partnership with the OmniGuide™ Institute for Biomedical Innovation.

"UROTECH is known for its customer focus and the user-centric development and distribution of innovative solutions for urologists worldwide. The partnership with OmniGuide fits into this mindset, to make the revolutionary all-in-one RevoLix HTL laser technology and its great benefits available to our customers," said Dr. Markus Schönberger, Director Business Development and Head of the Strategic Business Unit Urology of the Medi-Globe Group.

"Biosensing Innovation is increasing both the need to collaborate and share data," said M.T. Henderson CEO OmniGuide Holdings™ (OGH). "Solutions that connect outcomes with recent technology are at the core of our collective purpose. We are proud to partner with UROTECH to expand our shared vision of helping to improve patient lives, fueled by innovation-forward therapies."

About OmniGuide Holdings

Headquartered in Billerica, Massachusetts, USA, OmniGuide is a leader in the design, development, and marketing of patient safety-focused advanced energy surgical tools to benefit clinicians and their patients. OmniGuide is a privately held company, majority owned by an investment fund managed by OrbiMed Advisors LLC.


UROTECH is a Medi-Globe Group company, which is part of DCC Healthcare, one of three divisions of DCC plc, an Ireland-based FTSE 100 listed company. The head office of UROTECH is in Achenmühle in Chiemgau, Bavaria, south of Munich, Germany.

The Medi-Globe Group is an innovative, fast-growing, and internationally oriented group of medical technology companies in the fields of urology, gastroenterology and pneumology.

UROTECH serves its customers including university hospitals, specialist clinics, and special medical facilities in 50 countries worldwide.

Media Contact
Iris Schäfer Medi-Globe Group:
Tullio Cappelletto OmniGuide Holdings:

Contact Information

Iris Schäfer

Tullio Cappelletto

SOURCE: OmniGuide Holdings (OGH)


View the original press release on

DynaResource, Inc. Appoints Directors

Dr. Quinton Hennigh and Mr. Brent Omland Appointed to Company’s Board of Directors

IRVING, TX / ACCESSWIRE / February 22, 2024 / DYNR-DynaResource, Inc. (OTCQB:DYNR) ("DynaUSA", and "the Company") is pleased to announce that it has appointed Dr. Quinton Hennigh and Mr. Brent Omland as Directors to the Board of Directors of the Company; and that the Company accepted the resignations of Dr. Jose Vargas Lugo and Mr. Ronald Vail from the Company’s Board of Directors in order to make the two Board Seats available. The appointments and resignations are effective February 16, 2024. Dr. Vargas Lugo will remain in his position with the Company as Director of Operations – Mexico, and Mr. Vail will become a non-voting Board observer.

Dr. Hennigh is an exploration geologist with 33 years’ experience, predominantly in the gold industry. He holds a M.Sc. and Ph.D. in geology and geochemistry from the Colorado School of Mines. Early in his career, he explored for gold for major mining companies including Homestake Mining Company, Newcrest Mining Ltd., and Newmont Mining Corporation. Beginning in 2007, Dr. Hennigh shifted focus to the junior mining space where he has worked for several successful gold explorers, notably Gold Canyon Resources where he led the discovery of the 5.2 million ounce Springpole gold deposit, Ontario. Currently, Dr. Hennigh is Technical and Geologic Director to Crescat Capital and is CEO of private miner, San Cristobal Mining.

Mr. Omland was elected to serve as a Director pursuant to the terms of the Stock Purchase Agreement (the "Stock Purchase Agreement") dated August 2, 2023, by and between the Company and Ocean Partners Holdings Limited ("Ocean Partners"). Mr. Omland is the Co-CEO of Ocean Partners, which purchases substantially all the gold produced by the Company pursuant to that certain Gold Concentrate Purchase Agreement dated February 1, 2021, as amended, by and between the Company’s affiliate, DynaResource de Mexico, SA de CV ("DynaMéxico’), and an affiliate of Ocean Partners, MK Metal Trading Mexico SA de CV.

Mr. Omland is a mining executive with 20 years of experience in the mining and metals trading industry. Mr Omland is a graduate of the University of British Columbia and a Canadian CPA. Mr. Omland has also worked in finance roles for Teck Resources and in senior finance roles for an integrated lead mining and smelting group based in Australia (Ivernia/Enirgi Metals). Mr. Omland also serves on the Board of Directors for Dore Copper Mining Corp, Galantas Gold Corporation and Nicola Mining Inc., all listed on the TSX-V.

Mr. K.D. Diepholz, Chairman of the Board of Directors and CEO of DynaResource, Inc., and President of DynaMéxico, which currently owns 100% of the prolific San Jose de Gracia high grade gold project in Sinaloa State, Mexico ("SJG"); stated: "I am very pleased to add the expertise of an internationally renowned mining professional such as Dr. Hennigh to our Board of Directors. We look forward to utilizing his expertise and experience as we continue to expand the operations and resources at SJG.

I also greatly appreciate the attention and support we have received from Mr. Omland and Ocean Partners since February 2021, and I am pleased to welcome Brent to the Board of Directors. Quinton and Brent will be integral and valuable additions to the Board of Directors team, and I’m certain they will provide significant and strategic contributions to the further advance and development of the prolific SJG Project. I am excited and looking forward to working with Quinton and Brent.

I would also like to thank Dr. Jose Vargas Lugo and Mr. Ron Vail for their significant contributions to DynaResource over the past few years. Dr. Vargas will continue to be an integral executive for our management team, and Ron will continue to support our strategic business planning. Dr. Vargas and Ron have both contributed greatly to the significant achievements made by DynaResource."

"I am delighted to join DynaResource alongside Brent Omland," commented Dr. Hennigh. "San José de Gracia is an exceptional low sulfidation epithermal vein camp that I have kept my eye on for many years. While it is famous for its historic high-grade gold production, I believe this is a system that remains grossly under-explored. I can see several immediate targets in which new high-grade veins might be discovered. I look forward to helping DynaResource develop their current resources as well as pursue the next generation of discoveries yet to be made at San José de Gracia."

On behalf of Ocean Partners, Mr. Brent Omland, co-CEO of Ocean Partners commented: "We are very pleased to expand our strong relationship with DynaResource and their excellent team in the US and México. We are excited to be a part of the continuing development and expansion of the world class SJG Project and we look forward to providing K.D. and his team additional support and resources."


The Company is an "OTC Reporting Issuer" as that term is defined in Multilateral Instrument 51-509, Issuers Quoted in the U.S. Over-the-Counter Markets, promulgated by various Canadian Provincial Securities Commissions. Accordingly, certain disclosure in this news release or other disclosure provided by the Company has been prepared in accordance with the requirements of securities laws in effect in Canada, which differ from the requirements of United States securities laws. In Canada, an issuer is required to provide technical information with respect to mineralization, including reserves and resources, if any, on its mineral exploration properties in accordance with Canadian requirements, which differ significantly from the requirements of the United States Securities and Exchange Commission (the "SEC") applicable to registration statements and reports filed by United States companies pursuant to the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. As such, information contained in this news release or other disclosure provided by the Company concerning descriptions of mineralization under Canadian standards may not be comparable to similar information made public by United States companies subject to the reporting and disclosure requirements of the SEC and not subject to Canadian securities legislation. This news release or other disclosure provided by the Company may use the terms "measured mineral resources", "indicated mineral resources" and "inferred mineral resources". While these terms are recognized and required by Canadian regulations (under National Instrument 43-101, Standards of Disclosure for Mineral Projects), the SEC does not recognize them. United States investors are cautioned not to assume that any part or all of the mineral deposits in these categories will ever be converted to reserves. In addition, "inferred mineral resources" have a great amount of uncertainty as to their existence and economic and legal feasibility. It cannot be assumed that all or any part of an inferred mineral resource will ever be upgraded to a higher category. Under Canadian securities legislation, estimates of inferred mineral resources may not form the basis of feasibility or pre-feasibility studies, although they may form, in certain circumstances, the basis of a "preliminary economic assessment" as that term is defined in National Instrument 43-101, Standards of Disclosure for Mineral Projects. U.S. investors are cautioned not to assume that part or all of an inferred mineral resource exists, or is economically or legally mineable.


This news release contains forward-looking statements within the meaning of Section 27 A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

Certain information contained in this news release, including any information relating to future financial or operating performance may be deemed "forward-looking". All statements in this news release, other than statements of historical fact, that address events or developments that DynaResource expects to occur, are "forward-looking information". These statements relate to future events or future performance and reflect the Company’s expectations regarding the future growth, results of operations, business prospects and opportunities of DynaResource. These forward-looking statements reflect the Company’s current internal projections, expectations or beliefs and are based on information currently available to DynaResource. In some cases, forward-looking information can be identified by terminology such as "may", "will", "should", "expect", "intend", "plan", "anticipate", "believe", "estimate", "projects", "potential", "scheduled", "forecast", "budget" or the negative of those terms or other comparable terminology. Certain assumptions have been made regarding the Company’s plans at the San Jose de Gràcia property. Many of these assumptions are based on factors and events that are not within the control of DynaResource and there is no assurance they will prove to be correct. Such factors include, without limitation: capital requirements, fluctuations in the international currency markets and in the rates of exchange of the currencies of the United States and México; price volatility in the spot and forward markets for commodities; discrepancies between actual and estimated production, between actual and estimated reserves and resources and between actual and estimated metallurgical recoveries; changes in national and local governments in any country which DynaResource currently or may in the future carry on business; taxation; controls; regulations and political or economic developments in the countries in which DynaResource does or may carry on business; the speculative nature of mineral exploration and development, including the risks of obtaining necessary licenses and permits, diminishing quantities or grades of reserves; competition; loss of key employees; additional funding requirements; actual results of current exploration or reclamation activities; changes in project parameters as plans continue to be refined; accidents; labor disputes; defective title to mineral claims or property or contests over claims to mineral properties. In addition, there are risks and hazards associated with the business of mineral exploration, development and mining, including environmental hazards, industrial accidents, unusual or unexpected formations, pressures, cave-ins, flooding and gold bullion losses (and the risk of inadequate insurance or inability to obtain insurance, to cover these risks) as well as those risks referenced in the Annual Report for DynaResource available at Forward-looking information is not a guarantee of future performance and actual results, and future events could differ materially from those discussed in the forward-looking information. All of the forward-looking information contained in this news release is qualified by these cautionary statements. Although DynaResource believes that the forward-looking information contained in this news release is based on reasonable assumptions, readers cannot be assured that actual results will be consistent with such statements. Accordingly, readers are cautioned against placing undue reliance on forward-looking information. DynaResource expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.

For Information on DynaUSA and DynaMéxico, please visit, or contact:

Brad J. Saulter, DynaUSA V.P. – Investor Relations: 972-996-7417; General Inquiries: 972-869-9400
K.D. Diepholz, DynaUSA – Chairman / CEO
DynaResource de México-Presidente

Contact Information

Brad J. Saulter
DynaUSA V.P. – Investor Relations

SOURCE: DynaResource, Inc.


View the original press release on

Fortrea เพิ่มความสามารถในการเข้าถึงผู้ป่วยและความเชี่ยวชาญด้านห่วงโซ่ความเย็นด้วยการขยาย FortreaRx™

การขยายร้านขายยาเฉพาะทางที่ไม่ใช่เชิงพาณิชย์ของ Fortrea มอบโซลูชันที่ยืดหยุ่นและปรับขนาดได้ให้แก่ลูกค้า อีกทั้งมอบยาที่เปลี่ยนแปลงชีวิตได้ถึงผู้ป่วยโดยตรง

เดอร์แฮม นอร์ทแคโรไลนา, Feb. 22, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (หรือเรียกว่า “บริษัท”) ซึ่งเป็นองค์กรวิจัยตามสัญญา (CRO) ชั้นนำระดับโลก ประกาศเปิด FortreaRx™ ซึ่งร้านขายยาเฉพาะทางที่ไม่ใช่เชิงพาณิชย์ที่กำลังเจริญเติบโต โดยตั้งอยู่ในเมืองเลกแมรี รัฐฟลอริดา ซึ่งนำเสนอโซลูชันการเข้าถึงผู้ป่วยขั้นสูงทั่วสหรัฐอเมริกา รวมถึงความสามารถและความเชี่ยวชาญในการจัดจำหน่ายแบบอุณหภูมิโดยรอบและแบบเย็น

FortreaRx ได้รับใบอนุญาตใน 50 รัฐและดินแดนของสหรัฐอเมริกา โดยนำเสนอโซลูชันที่ยืดหยุ่นและปรับขนาดได้ ซึ่งตอบสนองความต้องการเฉพาะของลูกค้า ในขณะเดียวกันก็จัดหายาให้กับผู้ป่วยที่อาจไม่สามารถเข้าถึงได้ ร้านขายยาเฉพาะทางที่ไม่ใช่เชิงพาณิชย์ เช่น FortreaRx นำเสนอโซลูชันเหล่านี้ในนามของลูกค้าผู้ผลิตยาของตน และอยู่ในตำแหน่งที่ไม่เหมือนใครในการทำหน้าที่เป็นสะพานเชื่อมระหว่างผู้ผลิตยาและผู้ป่วยที่มีคุณสมบัติตรงตามข้อกำหนดของผู้ผลิตสำหรับการรับความช่วยเหลือในการสั่งจ่ายยา

นับตั้งแต่ก่อตั้ง FortreaRx ในปลายปี 2551 Fortrea ได้บุกเบิกบริการร้านขายยาเฉพาะทางที่ไม่ใช่เชิงพาณิชย์ โดยมุ่งเน้นที่การจำหน่ายผลิตภัณฑ์แจกฟรี ซึ่งเป็นองค์ประกอบบูรณาการของโครงการช่วยเหลือผู้ป่วย (Patient Assistance Programs หรือ PAP) ที่ผู้ผลิตยาสนับสนุน โดยออกแบบมาเพื่อขยายการเข้าถึงในการบำบัดให้แก่ผู้มีคุณสมบัติเหมาะสม ผู้ป่วยที่ไม่มีประกันสุขภาพหรือผู้ที่ไม่ได้รับความคุ้มครอง โรงงาน FortreaRx ตั้งอยู่บนพื้นที่ 40,000 ตารางฟุต โดยเพิ่มพื้นที่การดำเนินงานเป็นสองเท่า อีกทั้งยังเพิ่มขีดความสามารถต่าง ๆ โดยมี:

  • พื้นที่จัดเก็บโดยรอบ 1,800 ตารางฟุต
  • พื้นที่จัดเก็บห้องเย็นขนาด 6,000 ตารางฟุต โดยใบสั่งยามากกว่า 85 เปอร์เซ็นต์ที่กรอกโดย FortreaRx นั้นต้องการการจัดการที่เป็นเอกลักษณ์นี้
  • พื้นที่การประมวลผลและการดำเนินการที่มากขึ้น โดยรองรับใบสั่งยาได้มากถึง 18,000 รายการต่อวัน
  • โซลูชันการจัดส่งที่ได้รับการปรับปรุงพร้อมตัวเลือกสำหรับการจัดส่งแบบข้ามคืน แบบเร่งด่วน และแบบ 2 วัน

“ข้อเสนอการบริการผู้ป่วยที่มีชื่อเสียงของ Fortrea ได้ผสมผสานกับความสามารถที่เพิ่มขึ้นของ FortreaRx จึงทำให้สามารถมอบแนวทางแบบครบวงจร ตั้งแต่ขั้นตอนการรักษาทางคลินิกระยะแรกไปจนถึงการมอบแนวทางหลังอออกสู่ตลาด ทำให้มั่นใจได้ว่าผู้ป่วยจะได้รับประสบการณ์ที่ครอบคลุมและเป็นส่วนตัว” Bill Nolan รองประธานและหัวหน้าฝ่ายการเข้าถึงผู้ป่วยระดับโลกของ Fortrea กล่าว “Fortrea เป็นเลิศในการส่งมอบโซลูชันที่ทันท่วงทีและมีประสิทธิภาพแก่ผู้สนับสนุนด้านเภสัชกรรมของเรา ตั้งแต่ความเชี่ยวชาญของเราในเรื่องของโรคในวงกว้างไปจนถึงความมุ่งมั่นอย่างแน่วแน่ในการช่วยเหลือผู้ป่วย บริษัทมุ่งมั่นที่จะลดความท้าทายของผู้ป่วยและผู้ให้บริการด้วยการปรับปรุงกระบวนการลงทะเบียนให้มีประสิทธิภาพ และโดยนำเสนอการบูรณาการเต็มรูปแบบด้วยความคิดริเริ่มในการสนับสนุนผู้ป่วยในวงกว้างมากยิ่งขึ้น”

ศูนย์กลางคอลเซ็นเตอร์สำหรับผู้จัดการเคสต่าง ๆ ของ FortreaRx นั้นช่วยจัดการข้อซักถามของผู้ป่วย การให้คำปรึกษา และการตรวจสอบข้อมูลใบสั่งยาได้อย่างราบรื่น ทีมการเข้าถึงผู้ป่วยของ Fortrea ช่วยให้ผู้ป่วยและผู้ให้บริการเข้าใจและสามารถจัดการกับความซับซ้อนของความครอบคลุม และในขณะเดียวกันก็ขจัดอุปสรรคในการรับยาให้กับผู้ป่วยอีกด้วย

FortreaRx นำเสนอโซลูชันที่มีประสิทธิภาพ ให้คำปรึกษา และคุ้มค่าสำหรับโปรแกรมใบสั่งยาของผู้ผลิต ซึ่งโดยทั่วไปแล้วส่งผลให้ผู้ป่วยประหยัดเงินได้มากต่อปี

สำหรับข้อมูลเพิ่มเติมเกี่ยวกับ FortreaRx และบริการต่าง ๆ กรุณาเยี่ยมชม

เกี่ยวกับ Fortrea

Fortrea (Nasdaq: FTRE) เป็นผู้ให้บริการชั้นนำระดับโลกด้านการพัฒนาทางคลินิกและโซลูชันการเข้าถึงผู้ป่วยในอุตสาหกรรมวิทยาศาสตร์เพื่อชีวิต เราร่วมมือกับบริษัทชีวเภสัชภัณฑ์ บริษัทอุปกรณ์ทางการแพทย์ และบริษัทวินิจฉัยที่เกิดขึ้นใหม่และขนาดใหญ่เพื่อขับเคลื่อนนวัตกรรมด้านการดูแลสุขภาพที่เร่งการรักษาที่เปลี่ยนแปลงชีวิตให้กับผู้ป่วยที่ต้องการความช่วยเหลือ Fortrea ให้บริการการจัดการการทดลองทางคลินิกระยะที่ 1-4 เภสัชวิทยาคลินิก โซลูชันการทดลองที่ใช้เทคโนโลยีที่แตกต่าง และบริการหลังการอนุมัติ โซลูชันของ Fortrea อาศัยประสบการณ์สามทศวรรษที่ครอบคลุมสาขาการรักษามากกว่า 20 สาขา ความหลงใหลในความเข้มงวดทางวิทยาศาสตร์ ข้อมูลเชิงลึกที่ยอดเยี่ยม และเครือข่ายไซต์ผู้ตรวจสอบที่แข็งแกร่ง ทีมงานที่มีความสามารถและหลากหลายของเราซึ่งมีพนักงานประมาณ 19,000 คนในกว่า 90 ประเทศได้รับการปรับขนาดเพื่อนำเสนอโซลูชันที่เจาะจงและคล่องตัวให้แก่ลูกค้าทั่วโลก สามารถเรียนรู้เพิ่มเติมเกี่ยวกับวิธีที่ Fortrea กลายเป็นพลังแห่งการเปลี่ยนแปลงจากขั้นตอนไปสู่ผู้ป่วยได้ที่ และติดตามเราได้บน LinkedIn และ X (ชื่อเดิมคือ Twitter) @Fortrea

ติดต่อ Fortrea:
Fortrea Media: Galen Wilson – 703-298-0802,
Fortrea Media: Kate Dillon – 646-818-9115,

GlobeNewswire Distribution ID 9041107

Further efforts needed to solve human resources shortage for semiconductor industry: Experts

Hanoi: As Vietnam is calling for investment in the semiconductor industry, experts held that the country should work harder to make a breakthrough in human resources development serving the growth of the industry.

Data from the national science and technology portal showed that as of the end of 2023, Vietnam had recorded more than 5,500 chip design engineers. Meanwhile, the country needs 5,000-10,000 engineers each year, but its human resources supply capacity is only less than 20%.

Semiconductor products have been defined by the Government as one of the nine national products in the country’s efforts to actively engage in the Fourth Industrial Revolution.

With an investment increase seen in the semiconductor industry recently, Vietnam can become a partner of many big countries in the field.

A report by Technavio predicted that the Vietnamese semiconductor market may expand about 6.5% each year in the 2021-2025 period. However, human resources shortage has been the greatest challenge of the industry.

ording to the Ministry of Education and Training (MoET), currently, Vietnam has 35 tertiary training establishments capable of providing semiconductor training programmes, but the number of experienced ones is few.

MoET Deputy Minister Hoang Minh Son said that human resources shortage is one of the major factors making investors hesitate to pour their money into Vietnam.

He stressed that along with support from the State, training facilities should actively cooperate with businesses and investors in human resources training, developing the labour market and attracting more investment.

Son said that the MoET is building an action plan to speedy increase the quality and quantity of human resources in the field of semiconductor, especially IC design engineers.

The most important task is to promote the capacity of training facilities, especially the quality of lecturers and infrastructure system, he underlined.

He also stressed the need to attract students to the area of semiconductor, and reaching cooperati
on agreements between tertiary training facilities with businesses and localities in the field./.

Source:Vietnam News Agency

China clam harvesting destroys 16K acres in SCS – study

MANILA: A new study has blamed China’s dredging and clam harvesting activities for the destruction of almost 20,000 acres of reefs in the South China Sea (West Philippine Sea).

In a briefing in Mandaluyong on Thursday, Asia Maritime Transparency Initiative (AMTI) research associate Monica Sato said the giant clam harvesting by Chinese fishers damaged at least 16,353 acres of coral reef in the disputed waters.

Sato explained that giant clams have become popular in China because of its resemblance to elephant ivory.

‘So, because it’s so similar to ivory, it became very popular in Chinese statuary, jewelry, and was sold for very high prices. The most expensive processed giant clam was sold for about USD106,000,’ she said.

The report titled Deep Blue Scars: Environmental Threats to the South China Sea, to which Sato was the lead author, was first released in 2023.

It assessed a total of 181 satellite imagery of occupied and unoccupied features in the South China Sea.

On top of clam harvesting, the study als
o attributed to China’s island building efforts the damage to an additional 4,000 acres of coral reef in the area.

Sato said China mainly did dredging and landfill between 2013 and 2017 using the method ‘cutter-suction dredging,’ where dredgers slice through the reefs and pump in the sediments through floating pipelines.

‘Just try to imagine a drill going through the reef- that’s essentially what China’s doing,’ she explained.

The study noted that dredging has always damaged the surrounding environment, but other claimants ‘have a history of using less destructive dredging methods’.

Until recently, it said Vietnam primarily used clamshell dredgers to scoop up sections of shallow reef and deposit the sediment on the area targeted for landfill.

The study said this method still destroys the coral reef but is much slower and causes less collateral damage to surrounding areas.

‘When we totaled, we found that China has destroyed 4,500 acres of reef through dredging and landfill, Vietnam comes in second with 1
,500 acres of reefs destroyed, and Malaysia and the Philippines and Taiwan barely scratched the surface- they contribute to less than 100 acres of destroyed reefs,’ she said.

One of the authors AMTI Director Greg Poling also said the ‘only way to stop this is to convince Beijing to stop this’.

‘Any effort to physically prevent this is going to be hopeless,’ he said.

‘We need to see an international coalition starting with Southeast Asia led by the claimants to better survey this damage, account for it, and hopefully negotiate some joint marine scientific research and fisheries management regimes among the Southeast Asian claimants,’ he said.

Source: Philippines News Agency

TESDA, UPM to develop training on biomedical equipment servicing

MANILA: The Technical Education and Skills Development Authority (TESDA) and the University of the Philippines – Manila (UPM) will work together in developing a training course on biomedical equipment servicing, specifically targeting new and state-of-the art equipment.

“This is the first time we will collaborate in this field, because there are new technologies being used in the health services sector,” TESDA Partnerships and Linkages Office Director Floramel Joy Songsong told the Philippine News Agency on Thursday.

While TESDA already offers Biomedical Equipment Servicing NC II, Songsong noted that the UPM needs technicians to maintain new equipment.

Songsong said the partnership seeks to develop competency standards and microcredentialing on Biomedical Equipment Servicing for new emerging skill set requirements for Anatomy, Laboratory and Simulation Technology Center Maintenance including Plastanated Soft Cadaver Maintenance.

“This (kind of training) is in demand now, because there are doctors who do t
he work of technicians,” she said.

She noted that UPM personnel are experts in developing the content for competency standards, while TESDA is an expert in the development process.

A memorandum of agreement between the two is being finalized for signing by the second week of March, she added.

Meanwhile, according to UPM, the partnership would meet the growing demand for skilled healthcare and health sciences education professionals.

“We utilize simulation-based education and technology-driven teaching method for our anatomy classes. TESDA and UPM can co-create and offer courses that are geared toward operating and maintaining biomedical equipment needed for such classes. This will be beneficial to schools and state universities who utilize a similar technology for their medical, nursing and health sciences classes,” UPM Chancellor Michael Tee said in a news release.

Other aspects of the collaboration aim to offer certification courses to medical and dental professionals, community pharmacies, and disaste
r response personnel, the UPMS said.

Source: Philippines News Agency